{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:54:04Z","timestamp":1773410044495,"version":"3.50.1"},"reference-count":109,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/mop.0000000000000251","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T12:49:51Z","timestamp":1434631791000},"page":"525-533","source":"Crossref","is-referenced-by-count":25,"title":["Advances in the detection and management of cystic fibrosis related diabetes"],"prefix":"10.1097","volume":"27","author":[{"given":"Shihab","family":"Hameed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Jaff\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles F.","family":"Verge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20-20210206","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJM196908282810901","article-title":"Glucose intolerance in cystic fibrosis.","volume":"281","author":"Handwerger","year":"1969","journal-title":"N Engl J Med"},{"key":"R3-20-20210206","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/adc.44.235.351","article-title":"Blood glucose and serum insulin levels in children with cystic fibrosis.","volume":"44","author":"Milner","year":"1969","journal-title":"Arch Dis Child"},{"key":"R4-20-20210206","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-3476(77)81241-9","article-title":"Pancreatic alpha and beta cell functions in cystic fibrosis.","volume":"90","author":"Lippe","year":"1977","journal-title":"J Pediatr"},{"key":"R5-20-20210206","first-page":"253","article-title":"Glucose intolerance in cystic fibrosis patients.","volume":"2","author":"Lanng","year":"2001","journal-title":"Paediatr Respir Rev"},{"key":"R6-20-20210206","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3476(98)70171-4","article-title":"Abnormal glucose metabolism in cystic fibrosis.","volume":"133","author":"Moran","year":"1998","journal-title":"J Pediatr"},{"key":"R7-20-20210206","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/BF01957574","article-title":"Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis.","volume":"151","author":"Lanng","year":"1992","journal-title":"Eur J Pediatr"},{"key":"R8-20-20210206","first-page":"860","article-title":"Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy.","volume":"90","author":"Rolon","year":"2001","journal-title":"Acta Paediatr"},{"key":"R9-20-20210206","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1464-5491.2009.02738.x","article-title":"Mechanisms of glucose intolerance in cystic fibrosis.","volume":"26","author":"Mohan","year":"2009","journal-title":"Diabet Med"},{"key":"R10-20-20210206","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/080352501750197647","article-title":"Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus.","volume":"90","author":"Nousia-Arvanitakis","year":"2001","journal-title":"Acta Paediatr"},{"key":"R11-20-20210206","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/ajcn\/36.3.492","article-title":"Altered body composition and muscle protein degradation in nutritionally growth-retarded children with cystic fibrosis.","volume":"36","author":"Miller","year":"1982","journal-title":"Am J Clin Nutr"},{"key":"R12-20-20210206","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/ajcn\/41.5.1061","article-title":"Whole body protein turnover in malnourished cystic fibrosis patients and its relationship to pulmonary disease.","volume":"41","author":"Holt","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"R13-20-20210206","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-3476(88)80315-9","article-title":"Diabetes mellitus associated with cystic fibrosis.","volume":"112","author":"Finkelstein","year":"1988","journal-title":"J Pediatr"},{"key":"R14-20-20210206","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2337\/diacare.28.9.2141","article-title":"Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis.","volume":"28","author":"Milla","year":"2005","journal-title":"Diabetes Care"},{"key":"R15-20-20210206","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality.","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"R17-20-20210206","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00718598","article-title":"Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study.","volume":"414","author":"Lohr","year":"1989","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"R18-20-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/15513818609025923","article-title":"Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies.","volume":"6","author":"Soejima","year":"1986","journal-title":"Pediatr Pathol"},{"key":"R19-20-20210206","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0046-8177(84)80191-4","article-title":"Endocrine pancreas in cystic fibrosis: an immunohistochemical study.","volume":"15","author":"Iannucci","year":"1984","journal-title":"Hum Pathol"},{"key":"R20-20-20210206","first-page":"1267","article-title":"Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis.","volume":"81","author":"Couce","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-20-20210206","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jcu.1870130707","article-title":"Ultrasound characteristics of the pancreas in children with cystic fibrosis.","volume":"13","author":"Swobodnik","year":"1985","journal-title":"J Clin Ultrasound"},{"key":"R22-20-20210206","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/016173468000200103","article-title":"Amplitude analysis of pancreatic B-scans: a clinical evaluation of cystic fibrosis.","volume":"2","author":"Shawker","year":"1980","journal-title":"Ultrason Imaging"},{"key":"R23-20-20210206","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/adc.59.10.923","article-title":"Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis.","volume":"59","author":"Wilson-Sharp","year":"1984","journal-title":"Arch Dis Child"},{"key":"R24-20-20210206","first-page":"602","article-title":"Islets of Langerhans in adolescents and adults with cystic fibrosis. A quantitative study.","volume":"110","author":"Abdul-Karim","year":"1986","journal-title":"Arch Pathol Lab Med"},{"key":"R25-20-20210206","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2337\/db09-1151","article-title":"Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax.","volume":"59","author":"McKenzie","year":"2010","journal-title":"Diabetes"},{"key":"R26-20-20210206","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2337\/diab.24.9.820","article-title":"Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents.","volume":"24","author":"Rosenbloom","year":"1975","journal-title":"Diabetes"},{"key":"R27-20-20210206","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jpeds.2007.09.025","article-title":"Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis.","volume":"152","author":"Bismuth","year":"2008","journal-title":"J Pediatr"},{"key":"R28-20-20210206","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/acta.0.1280207","article-title":"Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.","volume":"128","author":"Lanng","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"R29-20-20210206","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/eje.1.01836","article-title":"Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.","volume":"152","author":"Tofe","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R30-20-20210206","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jpeds.2007.05.012","article-title":"Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes.","volume":"151","author":"Elder","year":"2007","journal-title":"J Pediatr"},{"key":"R31-20-20210206","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","article-title":"Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain.","volume":"33","author":"Hameed","year":"2010","journal-title":"Diabetes Care"},{"key":"R32-20-20210206","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcf.2006.03.009","article-title":"Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis.","volume":"6","author":"Brennan","year":"2007","journal-title":"J Cyst Fibros"},{"key":"R33-20-20210206","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis related diabetes without fasting hyperglycemia: results of the CFRDT trial.","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"R34-20-20210206","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/eje.0.1490053","article-title":"Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia.","volume":"149","author":"Lombardo","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"R35-20-20210206","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.2337\/db13-1464","article-title":"Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study.","volume":"63","author":"Soave","year":"2014","journal-title":"Diabetes"},{"key":"R36-20-20210206","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12020-007-9026-x","article-title":"Expression and localization of cystic fibrosis transmembrane conductance regulator in the rat endocrine pancreas.","volume":"32","author":"Boom","year":"2007","journal-title":"Endocrine"},{"key":"R37-20-20210206","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mehy.2008.07.058","article-title":"Is cystic fibrosis-related diabetes an apoptotic consequence of ER stress in pancreatic cells Med H","volume":"72","author":"Ali","year":"2009","journal-title":"ypotheses"},{"key":"R38-20-20210206","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/db05-1647","article-title":"Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury.","volume":"55","author":"Stalvey","year":"2006","journal-title":"Diabetes"},{"key":"R39-20-20210206","doi-asserted-by":"crossref","first-page":"36639","DOI":"10.1074\/jbc.M112.393637","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner.","volume":"287","author":"Eckford","year":"2012","journal-title":"J Biol Chem"},{"key":"R40-20-20210206","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pedi.12026","article-title":"Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.","volume":"14","author":"Bellin","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"R42-20-20210206","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1210\/jc.2008-2186","article-title":"Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis.","volume":"94","author":"Blackman","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-20-20210206","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s00125-009-1436-2","article-title":"A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis.","volume":"52","author":"Blackman","year":"2009","journal-title":"Diabetologia"},{"key":"R44-20-20210206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/CS20140059","article-title":"Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass.","volume":"128","author":"Uc","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"R45-20-20210206","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1515\/JPEM.2005.18.8.755","article-title":"Beta-cell autoantibodies and diabetes mellitus family history in cystic fibrosis.","volume":"18","author":"Minicucci","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R46-20-20210206","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1651-2227.1993.tb12628.x","article-title":"Diabetes mellitus in cystic fibrosis: genetic and immunological markers.","volume":"82","author":"Lanng","year":"1993","journal-title":"Acta Paediatr"},{"key":"R47-20-20210206","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fasebj.8.1.8299889","article-title":"Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures.","volume":"8","author":"Klip","year":"1994","journal-title":"FASEB J"},{"key":"R48-20-20210206","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJM198607243150402","article-title":"Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.","volume":"315","author":"Amiel","year":"1986","journal-title":"N Engl J Med"},{"key":"R49-20-20210206","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance.","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"R50-20-20210206","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-8227(99)00058-3","article-title":"Diagnosis, screening and management of cystic fibrosis related diabetes mellitus. A consensus conference report.","volume":"45","author":"Moran","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"key":"R51-20-20210206","first-page":"145","article-title":"Endocrine complications of cystic fibrosis.","volume":"13","author":"Moran","year":"2002","journal-title":"Adolesc Med"},{"key":"R52-20-20210206","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society.","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"R53-20-20210206","doi-asserted-by":"crossref","first-page":"e44844","DOI":"10.1371\/journal.pone.0044844","article-title":"Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis.","volume":"7","author":"Widger","year":"2012","journal-title":"PLoS One"},{"key":"R55-20-20210206","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/CS20030333","article-title":"Effect of hyperglycaemia on glucose concentration of human nasal secretions.","volume":"106","author":"Wood","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"R56-20-20210206","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/thx.2004.035766","article-title":"Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients.","volume":"60","author":"Philips","year":"2005","journal-title":"Thorax"},{"key":"R57-20-20210206","doi-asserted-by":"crossref","first-page":"e76283","DOI":"10.1371\/journal.pone.0076283","article-title":"Elevated paracellular glucose flux across cystic fibrosis airway epithelial monolayers is an important factor for Pseudomonas aeruginosa growth.","volume":"8","author":"Garnett","year":"2013","journal-title":"PLoS One"},{"key":"R58-20-20210206","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1183\/09031936.00166412","article-title":"Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry.","volume":"43","author":"Kerem","year":"2014","journal-title":"Eur Respir J"},{"key":"R59-20-20210206","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ppul.20619","article-title":"Predictors of mortality in adults with cystic fibrosis.","volume":"42","author":"Courtney","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"R60-20-20210206","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMoa1106126","article-title":"Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis.","volume":"366","author":"Chotirmall","year":"2012","journal-title":"N Engl J Med"},{"key":"R61-20-20210206","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/oxfordjournals.aje.a009172","article-title":"Gender gap in cystic fibrosis mortality.","volume":"145","author":"Rosenfeld","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R62-20-20210206","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ppul.20794","article-title":"Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients.","volume":"43","author":"Levy","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"R63-20-20210206","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ppul.10230","article-title":"Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening.","volume":"35","author":"Maselli","year":"2003","journal-title":"Pediatr Pulmonol"},{"key":"R64-20-20210206","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0022-3476(95)70080-3","article-title":"Genetic determination of diabetes mellitus in patients with cystic fibrosis. Multicenter Cystic Fibrosis Study Group.","volume":"127","author":"Rosenecker","year":"1995","journal-title":"J Pediatr"},{"key":"R65-20-20210206","first-page":"159","article-title":"Abnormal glucose tolerance in CF - when should we offer diabetes treatment Pediatr D","volume":"10","author":"Moran","year":"2009","journal-title":"iabetes"},{"key":"R66-20-20210206","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1210\/jc.2013-2756","article-title":"Impact of sex on insulin secretion in cystic fibrosis.","volume":"99","author":"Coriati","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R67-20-20210206","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ppul.1142","article-title":"Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis.","volume":"32","author":"Koch","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"R69-20-20210206","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1651-2227.1994.tb13156.x","article-title":"Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections.","volume":"83","author":"Lanng","year":"1994","journal-title":"Acta Paediatr"},{"key":"R70-20-20210206","first-page":"2333","article-title":"Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes Diabetes C","volume":"28","author":"Franzese","year":"2005","journal-title":"are"},{"key":"R71-20-20210206","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-5448.2008.00451.x","article-title":"One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements.","volume":"10","author":"Mozzillo","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"R72-20-20210206","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00005792-198611000-00004","article-title":"The interaction of 2 diseases: diabetes mellitus and cystic fibrosis.","volume":"65","author":"Rodman","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"R73-20-20210206","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1542\/peds.84.4.642","article-title":"Diabetic microangiopathy in patients with cystic fibrosis.","volume":"84","author":"Sullivan","year":"1989","journal-title":"Pediatrics"},{"key":"R74-20-20210206","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2337\/dc06-1576","article-title":"Microvascular complications in cystic fibrosis-related diabetes.","volume":"30","author":"Schwarzenberg","year":"2007","journal-title":"Diabetes Care"},{"key":"R75-20-20210206","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000271912","article-title":"Cystic fibrosis-related diabetes in childhood.","volume":"73","author":"ORiordan","year":"2010","journal-title":"Hormone Res Paediatr"},{"key":"R76-20-20210206","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/resp.12227","article-title":"Australian standards of care for cystic fibrosis-related diabetes.","volume":"19","author":"Middleton","year":"2014","journal-title":"Respirology"},{"key":"R77-20-20210206","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.311.7006.655","article-title":"Glucose tolerance in patients with cystic fibrosis: five year prospective study.","volume":"311","author":"Lanng","year":"1995","journal-title":"BMJ"},{"key":"R80-20-20210206","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/archsurg.1980.01380120003001","article-title":"Sepsis, glucose intolerance, and protein malnutrition: a metabolic paradox.","volume":"115","author":"Dahn","year":"1980","journal-title":"Arch Surg"},{"key":"R81-20-20210206","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/ppul.21127","article-title":"Growth in children with cystic fibrosis-related diabetes.","volume":"44","author":"Cheung","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"R82-20-20210206","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2007.03.006","article-title":"Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.","volume":"151","author":"Konstan","year":"2007","journal-title":"J Pediatr"},{"key":"R83-20-20210206","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1542\/peds.2007-3089","article-title":"Wisconsin Cystic Fibrosis Neonatal Screening Group. Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis.","volume":"123","author":"Lai","year":"2009","journal-title":"Pediatrics"},{"key":"R84-20-20210206","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/thorax.56.10.746","article-title":"Wasting as an independent predictor of mortality in patients with cystic fibrosis.","volume":"56","author":"Sharma","year":"2001","journal-title":"Thorax"},{"key":"R85-20-20210206","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcf.2008.12.001","article-title":"Use of the insulin pump in treat cystic fibrosis related diabetes.","volume":"8","author":"Hardin","year":"2009","journal-title":"J Cyst Fibros"},{"key":"R87-20-20210206","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2265.2002.01484.x","article-title":"The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.","volume":"56","author":"Ripa","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R88-20-20210206","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jcf.2007.02.005","article-title":"Increased glucose excursion in cystic fibrosis and its association with a worse clinical status.","volume":"6","author":"Costa","year":"2007","journal-title":"J Cyst Fibros"},{"key":"R89-20-20210206","first-page":"345","article-title":"Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome.","volume":"6","author":"Rosenecker","year":"2001","journal-title":"Eur J Med Res"},{"issue":"Suppl 12","key":"R90-20-20210206","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1399-5448.2009.00587.x","article-title":"Management of cystic fibrosis-related diabetes in children and adolescents.","volume":"10","author":"ORiordan","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"R93-20-20210206","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcf.2004.12.002","article-title":"Standards of care for patients with cystic fibrosis: a European consensus.","volume":"4","author":"Kerem","year":"2005","journal-title":"J Cyst Fibros"},{"key":"R94-20-20210206","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/diacare.21.6.943","article-title":"Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S.","volume":"21","author":"Allen","year":"1998","journal-title":"Diabetes Care"},{"key":"R95-20-20210206","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ppul.20831","article-title":"Management of cystic fibrosis related diabetes: a survey of UK cystic fibrosis centers.","volume":"43","author":"Mohan","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"R96-20-20210206","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(71)92303-8","article-title":"Diabetes mellitus in American (Pima) Indians.","volume":"2","author":"Bennett","year":"1971","journal-title":"Lancet"},{"key":"R98-20-20210206","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ppul.21495","article-title":"Cystic fibrosis related diabetes (CFRD) - the end stage of progressive insulin deficiency.","volume":"46","author":"Hameed","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"R99-20-20210206","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1464-5491.2004.01219.x","article-title":"Conventional measures underestimate glycaemia in cystic fibrosis patients.","volume":"21","author":"Dobson","year":"2004","journal-title":"Diabet Med"},{"key":"R100-20-20210206","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.jcf.2013.06.001","article-title":"Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.","volume":"13","author":"Schmid","year":"2014","journal-title":"J Cyst Fibros"},{"key":"R102-20-20210206","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.2337\/diacare.26.6.1940-a","article-title":"Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis.","volume":"26","author":"Dobson","year":"2003","journal-title":"Diabetes Care"},{"key":"R103-20-20210206","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc08-1925","article-title":"Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study.","volume":"32","author":"ORiordan","year":"2009","journal-title":"Diabetes Care"},{"key":"R104-20-20210206","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-2008-1062723","article-title":"Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.","volume":"40","author":"Moreau","year":"2008","journal-title":"Horm Metab Res"},{"key":"R105-20-20210206","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jpeds.2005.05.004","article-title":"Continuous glucose monitoring in adolescents with cystic fibrosis.","volume":"147","author":"Jefferies","year":"2005","journal-title":"J Pediatr"},{"key":"R106-20-20210206","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jcf.2013.11.005","article-title":"Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.","volume":"13","author":"Leclercq","year":"2013","journal-title":"J Cyst Fibros"},{"key":"R107-20-20210206","first-page":"25","article-title":"The present diagnosis and therapy of cystic fibrosis of the pancreas.","volume":"42","author":"Andersen","year":"1949","journal-title":"Proc R Soc Med"},{"key":"R108-20-20210206","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3476(86)80695-3","article-title":"Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease.","volume":"109","author":"Shepherd","year":"1986","journal-title":"J Pediatr"},{"key":"R109-20-20210206","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00005176-199208000-00007","article-title":"Nutritional rehabilitation in cystic fibrosis: a 5 year follow-up study.","volume":"15","author":"Dalzell","year":"1992","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R110-20-20210206","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-8227(99)00058-3","article-title":"Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report.","volume":"45","author":"Moran","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"key":"R111-20-20210206","first-page":"371","article-title":"Cystic fibrosis-related diabetes in children - gaps in the evidence Nat Rev E","volume":"6","author":"Rana","year":"2010","journal-title":"ndocrinol"},{"key":"R112-20-20210206","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1210\/jc.2004-0699","article-title":"Sulfonylurea induced beta-cell apoptosis in cultured human islets.","volume":"90","author":"Maedler","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R113-20-20210206","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2337\/diacare.24.10.1706","article-title":"Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.","volume":"24","author":"Moran","year":"2001","journal-title":"Diabetes Care"},{"key":"R114-20-20210206","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ncpendmet0920","article-title":"The effect of thiazolidinediones on BMD and osteoporosis.","volume":"4","author":"McDonough","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R115-20-20210206","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2337\/diab.45.10.1317","article-title":"Effects of glucose ingestion versus infusion on pulsatile insulin secretion. The incretin effect is achieved by amplification of insulin secretory burst mass.","volume":"45","author":"Porksen","year":"1996","journal-title":"Diabetes"},{"key":"R116-20-20210206","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2337\/dc09-2062","article-title":"Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database.","volume":"33","author":"Horton","year":"2010","journal-title":"Diabetes Care"},{"key":"R117-20-20210206","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.2337\/dc12-2504","article-title":"A critical analysis of the clinical use of incretin-based therapies: the benefits by far outweigh the potential risks.","volume":"36","author":"Nauck","year":"2013","journal-title":"Diabetes Care"},{"key":"R119-20-20210206","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/adc.2010.204636","article-title":"Once daily insulin detemir in cystic fibrosis with insulin deficiency.","volume":"97","author":"Hameed","year":"2012","journal-title":"Arch Dis Child"},{"key":"R120-20-20210206","doi-asserted-by":"crossref","first-page":"RC1","DOI":"10.1007\/BF03345538","article-title":"Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance.","volume":"29","author":"Bizzarri","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"R121-20-20210206","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/0003-4819-145-9-200611070-00009","article-title":"Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.","volume":"145","author":"Ceglia","year":"2006","journal-title":"Ann Intern Med"},{"key":"R122-20-20210206","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.2337\/dc14-0639","article-title":"Islet-after-lung transplantation in a patient with cystic fibrosis-related diabetes.","volume":"37","author":"Spijker","year":"2014","journal-title":"Diabetes Care"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:33:21Z","timestamp":1652488401000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201508000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000251","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}